Search Results - "Pan, Bernard"

Recurrent Hodgkin’s Disease Presenting as a Clinically Isolated Cavernous Sinus Syndrome by Soni, Aayesha Jalaluddin, Lee-Pan, Edward Bernard

“…Background. Hodgkin’s disease involving the central nervous system is uncommon and is usually seen in patients with uncontrolled systemic disease or those who…”
Get full text

981-P: Development of a Diabetes Navigator Toolkit to Support Diabetes Technology Uptake and Sustained Use-IMPACT Toolkit by Wolf, Risa M, Alver, Defne, Pan, Bernard, Parimi, Neha, Klopouh, Milana S, Liu, Thalia D, Liu, Abby D, Sidhaye, Aniket, Riekert, Kristin, Mathioudakis, Nestoras N

“…Advanced diabetes technologies (ADT), including continuous glucose monitors (CGMs), insulin pumps, and automated insulin delivery systems, improve glycemic…”
Get full text

523-P: Psychosocial Impact of COVID-19 on Pediatric Diabetes by DIMENTSTEIN, KAREN, YEE, SHANIQUE, VALENZUELA, JESSICA M., PAN, BERNARD, SNYDER, MEG, WOLF, RISA

“…Background: Individuals with diabetes have been disproportionately affected by the COVID-19 pandemic. Data on the impact of COVID-19 on youth with T1D is…”
Get full text

Psychosocial Impact of the COVID-19 Pandemic in Racially/Ethnically Diverse Youth With Diabetes by Valenzuela, Jessica M, Dimentstein, Karen, Yee, Shanique, Pan, Bernard, Snyder, Meg C, Wolf, Risa M

“…This study examined caregiver perceived impact of the Coronavirus Disease 2019 (COVID-19) pandemic on a diverse sample of U.S. youth with diabetes and their…”
Get full text

1100-P: Real-World Use of GLP-1 Agonists in Youth with Type 2 Diabetes Is Associated with Improvements in Hemoglobin A1c—A Multicenter Analysis by SAMUELS, STEPHANIE, CHAJECKI, ANASTASIA, HU, PAMELA, KAYSER, MICHELLE, WEYMAN, KATE, PAN, BERNARD, BROWN, ELIZABETH A., VAN NAME, MICHELLE A., WOLF, RISA M.

“…Background: Despite the high risk of diabetes complications at an early age in youth with type 2 diabetes (T2D), there are limited pharmacologic options to…”
Get full text

Real‐world use of glucagon‐like peptide‐1 receptor agonists in youth with type 2 diabetes is associated with short‐term improvements in HbA1c by Samuels, Stephanie L., Chajecki, Anastasia, Hu, Pamela, Kayser, Michelle, Weyman, Kate, Pan, Bernard, Brown, Elizabeth A., Van Name, Michelle, Wolf, Risa M.

“…Aim To assess the short‐term, real‐world use and effectiveness of glucagon‐like peptide‐1 receptor agonist (GLP‐1RA) medications in the management of type 2…”
Get full text

Healthcare utilization & disparities in pediatric diabetes care during COVID-19 by Dimentstein, Karen, Valenzuela, Jessica M., Yee, Shanique, Pan, Bernard, Snyder, Meg C., Wolf, Risa M.

“…Managing type 1 diabetes requires stringent management, frequent visits with medical providers, and regular screenings. The COVID-19 pandemic altered…”
Get full text

110-OR: Autonomous Artificial Intelligence Diabetic Eye Exams to Mitigate Disparities in Screening Completion by ZEHRA, ANUM, BROMBERGER, LEE A., PAN, BERNARD, SHEHADEH, ALIYAH, PATEL, DHRUVA, BROWN, ELIZABETH A., CHANNA, ROOMASA, ALVIN LIU, T.Y., LEHMANN, HAROLD, ABRÀMOFF, MICHAEL D., WOLF, RISA M.

“…Diabetic retinopathy (DR) is a complication of diabetes that can result in vision loss, but early detection and treatment through screening can prevent this…”
Get full text

A Novel Genetic Algorithm for Multicast Routing Problem on the QoS Constrain by Rung-Ching Chen, Chuen-Chieh Liao, Pan, B.R.-H., Lin-Yu Tseng

“…New technologies are continuously being applied to high-speed networks such as distribution systems, on-line video-services, and some other applications. These…”
Get full text

Recurrent Hodgkin's Disease Presenting as a Clinically Isolated Cavernous Sinus Syndrome by Soni, Aayesha Jalaluddin, Lee-Pan, Edward Bernard

“…BACKGROUNDHodgkin's disease involving the central nervous system is uncommon and is usually seen in patients with uncontrolled systemic disease or those who…”
Get full text